The University of Chicago Header Logo

Connection

Mark Ferguson to Recombinant Proteins

Back to Details
This is a "connection" page, showing publications Mark Ferguson has written about Recombinant Proteins.
Mark Ferguson
Connection Strength
0.007
Recombinant Proteins
  1. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.